Siemens forms molecular imaging division:
This article was originally published in Clinica
Following its $1bn acquisition of CTI Molecular Imaging, Siemens has formed a new division called Siemens Medical Solutions Molecular Imaging. The business combines CTI's PET activities with Siemens' nuclear medicine business. It will be led by Michael Reitermann, hitherto president of Siemens Nuclear Medicine, while its chief scientific advisor will be by Dr Ronald Nutt, founder and former president and CEO of CTI Molecular Imaging.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.